TY - JOUR
T1 - Sample collections from healthy volunteers for biological variation estimates' update
T2 - A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine
AU - Carobene, Anna
AU - Strollo, Marta
AU - Jonker, Niels
AU - Barla, Gerhard
AU - Bartlett, William A.
AU - Sandberg, Sverre
AU - Sylte, Marit Sverresdotter
AU - Røraas, Thomas
AU - Sølvik, Una Ørvim
AU - Fernandez-Calle, Pilar
AU - Díaz-Garzón, Jorge
AU - Tosato, Francesca
AU - Plebani, Mario
AU - Coşkun, Abdurrahman
AU - Serteser, Mustafa
AU - Unsal, Ibrahim
AU - Ceriotti, Ferruccio
N1 - We are grateful to the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) to the sponsorship that allowed the kick off of the project
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Biological variation (BV) data have many fundamental applications in laboratory medicine. At the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) the reliability and limitations of current BV data were discussed. The EFLM Working Group on Biological Variation is working to increase the quality of BV data by developing a European project to establish a biobank of samples from healthy subjects to be used to produce high quality BV data. The project involved six European laboratories (Milan, Italy; Bergen, Norway; Madrid, Spain; Padua, Italy; Istanbul, Turkey; Assen, The Netherlands). Blood samples were collected from 97 volunteers (44 men, aged 20-60 years; 43 women, aged 20-50 years; 10 women, aged 55-69 years). Initial subject inclusion required that participants completed an enrolment questionnaire to verify their health status. The volunteers provided blood specimens once per week for 10 weeks. A short questionnaire was completed and some laboratory tests were performed at each sampling consisting of blood collected under controlled conditions to provide serum, K2EDTA-plasma and citrated-plasma samples. Samples from six out of the 97 enroled subjects were discarded as a consequence of abnormal laboratory measurements. A biobank of 18,000 aliquots was established consisting of 120 aliquots of serum, 40 of EDTA-plasma, and 40 of citrated-plasma from each subject. The samples were stored at -80 °C. A biobank of well-characterised samples collected under controlled conditions has been established delivering a European resource to enable production of contemporary BV data.
AB - Biological variation (BV) data have many fundamental applications in laboratory medicine. At the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) the reliability and limitations of current BV data were discussed. The EFLM Working Group on Biological Variation is working to increase the quality of BV data by developing a European project to establish a biobank of samples from healthy subjects to be used to produce high quality BV data. The project involved six European laboratories (Milan, Italy; Bergen, Norway; Madrid, Spain; Padua, Italy; Istanbul, Turkey; Assen, The Netherlands). Blood samples were collected from 97 volunteers (44 men, aged 20-60 years; 43 women, aged 20-50 years; 10 women, aged 55-69 years). Initial subject inclusion required that participants completed an enrolment questionnaire to verify their health status. The volunteers provided blood specimens once per week for 10 weeks. A short questionnaire was completed and some laboratory tests were performed at each sampling consisting of blood collected under controlled conditions to provide serum, K2EDTA-plasma and citrated-plasma samples. Samples from six out of the 97 enroled subjects were discarded as a consequence of abnormal laboratory measurements. A biobank of 18,000 aliquots was established consisting of 120 aliquots of serum, 40 of EDTA-plasma, and 40 of citrated-plasma from each subject. The samples were stored at -80 °C. A biobank of well-characterised samples collected under controlled conditions has been established delivering a European resource to enable production of contemporary BV data.
KW - Biobank
KW - Biological variation
KW - Preanalytical phase
UR - http://www.scopus.com/inward/record.url?scp=84987761305&partnerID=8YFLogxK
U2 - 10.1515/cclm-2016-0035
DO - 10.1515/cclm-2016-0035
M3 - Article
C2 - 27169681
AN - SCOPUS:84987761305
SN - 1434-6621
VL - 54
SP - 1599
EP - 1608
JO - Clinical Chemistry and Laboratory Medicine (CCLM)
JF - Clinical Chemistry and Laboratory Medicine (CCLM)
IS - 10
ER -